Things To Do In SW Florida

By DEE-ANN DURBIN, Associated Press Business Writer

McDonald’s is cutting prices on some combo meals to woo back customers who’ve been turned off by the rising costs of grabbing a fast food meal.

The price drop may induce its rivals, who have run into some of the same pricing issues, to follow.

Starting Sept. 8, McDonald’s will offer Extra Value Meals, which combine select entrées like a Big Mac, an Egg McMuffin or a McCrispy sandwich with medium fries or hash browns and a drink. Prices will vary by location, but McDonald’s said Extra Value Meals will cost 15% less than ordering each of those items separately.

Related Articles

Nonprofits face a tough funding landscape. They hope better storytelling will bring more donations

Crash victims’ families prepare to make what could be their final plea for Boeing’s prosecution

Disney: What it costs to eat entire menu of Epcot food fest

OpenAI and Meta say they’re fixing AI chatbots to better respond to teens in distress read more

By The Associated Press

Swiss food giant Nestlé said Monday it dismissed its CEO Laurent Freixe after an investigation into an undisclosed relationship with a direct subordinate.

The maker of Nescafé drinks and Purina pet food said in a statement the dismissal was effective immediately. An investigation found the undisclosed romantic relationship with a direct subordinate violated Nestlé’s code of conduct.

Freixe, who had been CEO for a year, will be replaced by Philipp Navratil, a longtime Nestlé executive.

“This was a necessary decision,” said Chairman Paul Bulcke. “Nestlé’s values and governance are strong foundations of our company.”

The company didn’t give any other details about the investigation.

Freixe had been with Nestlé since 1986, holding roles around the world. When Nestlé revamped its geographic structure in January 2022, Freixe became CEO of Zone Latin America. In August 2024, he was tapped to replace then-CEO Mark Schneider in the top role, and started Sept. 1, 2024. read more

The investing information provided on this page is for educational purposes only. NerdWallet, Inc. does not offer advisory or brokerage services, nor does it recommend or advise investors to buy or sell particular stocks, securities or other investments.

A Reddit user recently asked for advice about whether to save for retirement, or for their young children’s future college expenses.

Related Articles

• 
  Trump plans a hefty tax on imported drugs, risking higher prices and shortages

• 
  SpaceX launch caps busy month, still on track to pass 100 Space Coast missions this year

• 
  In the sustainable age, how can batteries be safer? A company says it has the answer

• 
  4 key decisions for early retirement

• 
  Property insurance companies are thriving now. Are Floridians owed a refund?

Respondents urged the user to prioritize retirement. Take care of yourself, one said, so you won’t be a burden to your children one day.

You can take out loans for college, but not for retirement, another noted. read more

By PAUL WISEMAN and TOM MURPHY

WASHINGTON (AP) — President Donald Trump has plastered tariffs on products from almost every country on earth. He’s targeted specific imports including autos, steel and aluminum.

But he isn’t done yet.

Trump has promised to impose hefty import taxes on pharmaceuticals, a category of products he’s largely spared in his trade war. For decades, in fact, imported medicine has mostly been allowed to enter the United States duty free.

That’s starting to change. U.S. and European leaders recently detailed a trade deal that includes a 15% tariff rate on some European goods brought into the United States, including pharmaceuticals. Trump is threatening duties of 200% more on drugs made elsewhere.

“Shock and awe’’ is how Maytee Pereira of the tax and consulting firm PwC describes Trump’s plans for drugmakers. “This is an industry that’s going from zero (tariffs) to the potentiality of 200%.’’

Trump has promised Americans he’ll lower their drug costs. But imposing stiff pharmaceutical tariffs risks the opposite and could disrupt complex supply chains, drive cheap foreign-made generic drugs out of the U.S. market and create shortages. read more